Brought to you by:
The top 10 most popular Vascular Specialist stories in August
Our recent editorial on the status of the interview, one of the Presidential Addresses from the Vascular Annual Meeting (VAM), a slew of new science news from VAM—including well-received results on transcarotid revascularization (TCAR)—and the digital flipbook version of our…
‘The future is very bright for venous valve replacement’
The progress of two “promising” new devices in the venous valve replacement space were outlined during a Vascular Annual Meeting (VAM) special session co-hosted by the American Venous Forum (AVF). Wednesday afternoon. Ellen Dillavou, MD, associate professor of vascular surgery…
Study shows increase in risk of renal failure following lytic therapy for acute DVT
A large, single-centre retrospective study has revealed the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower-extremity deep vein thrombosis (DVT) is as high as 22%. This findings add “significant knowledge” to understanding the risks of lytic…
Boston Scientific and BD initiate venous stent recalls
Boston Scientific and BD have both initiated recalls of venous stents. According to a Food and Drug Administration (FDA) medical device recall notice posted May 21, Boston Scientific has recalled its Vici venous stent system (Vici SDS) and Vici RDS…
The top 10 most popular stories from April
Our April cover story on the links between electronic health records (EHRs) and physician burnout, the continuing problem of manels (or all-male speaking panels) at vascular surgery meetings, and some of the latest details on the 2021 Vascular Annual Meeting…
New data support ‘routine’ use of IVUS during iliac vein stenting to optimize stent patency
A recent study on iliac vein stenting showed better short and mid-term patency rates when intravascular ultrasound (IVUS) was utilized prior to stent deployment in addition to multiplanar venography compared to venography alone. The data were presented at VENOUS2021, the…
Researchers recommend national registries address geographical variation in DVT guideline implementation
A new review concludes that the implementation of clinical guidelines for the management of patients with deep vein thrombosis (DVT) varies among countries, from strict adherence to no adherence at all. “In this content,” suggest authors Carla Rognoni, PhD, of SDA…
Study: ELVeS Radial varicose vein laser therapy shows ‘excellent’ long-term results
ELVeS Radial laser system Long-term results of patients who underwent outpatient laser treatment for varicose veins at the great saphenous vein (GSV) or small saphenous vein (SSV) in 2008–2009 have been published in the Journal of Vascular Surgery: Venous and Lymphatic…
Vesper Medical announces first enrollment in the VIVID trial
Vesper Medical recently announced initiation of its Food and Drug Administration (FDA) investigational device exemption (IDE) study, VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper Duo venous stent system). The VIVID trial is a prospective, multicenter, single-arm study to…
AVF schedules education series for trainees, early-career practitioners
The American Venous Forum (AVF) is to stage a four-part series of educational sessions running the gamut of venous disorders aimed at residents, fellows and early-career practitioners in vascular surgery, interventional radiology and a host of other specialties. The live,…